Swee Yeok Chu

Directeur/Membre du Conseil chez SINGAPORE POST LIMITED

Profil

Swee Yeok Chu is currently Director at Biomedical Sciences Investment Fund Pte Ltd., Independent Non-Executive Director at Singapore Post Ltd. since 2018, Non-Executive Director at Singapore Suzhou Township Development Pte Ltd., Director at A-Bio Pharma Pte Ltd., Director at Alexandra Health Endowment Fund, Non-Executive Director at National Healthcare Group Pte Ltd. since 2017, and Non-Executive Director at Anext Bank Pte Ltd. since 2022.
Former roles include Chief Executive Officer at Bio*One Capital Pte Ltd. from 2004 to 2008, President, CEO & Executive Director at EDBI Pte Ltd. from 2019 to 2024, Director at Silecs International Pte Ltd., Director at MerLion Pharmaceuticals Pte Ltd., Independent Director at Pegasus Asia from 2022 to 2024, Director at S*BIO Pte Ltd., Director at ES Cell International Pte Ltd., Director at Alexandra Health System Pte Ltd., and Senior Advisor at EDB Investments Pte Ltd from 2023 to 2024.
Education includes undergraduate studies at the National University of Singapore.

Postes actifs de Swee Yeok Chu

Sociétés	Poste	Début
SINGAPORE POST LIMITED	Directeur/Membre du Conseil	01/09/2018
Biomedical Sciences Investment Fund Pte Ltd.	Directeur/Membre du Conseil	-
National Healthcare Group Pte Ltd.	Directeur/Membre du Conseil	01/10/2017
Alexandra Health Endowment Fund	Directeur/Membre du Conseil	-
Singapore Suzhou Township Development Pte Ltd.	Directeur/Membre du Conseil	-
A-Bio Pharma Pte Ltd.	Directeur/Membre du Conseil	-
Anext Bank Pte Ltd.	Directeur/Membre du Conseil	01/02/2022

Anciens postes connus de Swee Yeok Chu

Sociétés	Poste	Fin
EDB Investments Pte Ltd.	Directeur Général	01/02/2023
EDBI Pte Ltd.	Directeur Général	01/03/2024
░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░ ░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-